Grant from the Icelandic Technology Development Fund
EpiEndo is pleased to welcome Fredrik Lehmann to our team as the new CEO of EpiEndo.
EpiEndo Pharmaceuticals has signed a grant agreement today with the Icelandic Technology Development Fund. The Technology Development Fund’s role is to support research and development activities, which aim towards innovation in Icelandic industry. The Technology Development Fund is a competitive fund which issues its calls for proposals twice a year. The grant award is in the amount of ISK 50 million (EUR 400 thousand) and is awarded towards the pre-clinical development programs at EpiEndo.